Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Rises 22 Percent to Lead BCW Index

Shares in Stratagene rose 22.4 percent over the five-day trading period ended Tuesday, far outgaining any of the other stocks that comprise the BCW Index. The gain is likely the result of investors believing that a recent sell off was unwarranted. Two weeks ago, the firm's shares dropped nearly 19 percent on news that a jury found the firm had willfully infringed patents held by Third Wave Technologies and ordered Stratagene to pay damages of $5.3 million (see BioCommerce Week 9/8/2005).

Waters and Beckman Coulter shared the largest declines for the week, finishing down 6.1 percent for the tracking period. Overall, the Index fell 2.2 percent.

In comparison, the Dow Jones Industrial Average declined 1.1 percent, the Nasdaq closed down 1.9 percent, and the Nasdaq Biotech Index also declined .5 percent.

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(September 20, 2005)
Last Price
(September 13, 2005)
% Change
Agilent
A
34.03
33.09
2.84
Applied Biosystems
ABI
23.07
23.13
-0.26
Beckman
BEC
54.06
57.58
-6.11
Bio-Rad
BIO
52.28
54.48
-4.04
Bruker
BRKR
4.33
4.56
-5.04
Fisher Scientific
FSH
63.01
63.49
-0.76
GE
GE
33.84
34.28
-1.28
Harvard Bio
HBIO
2.84
2.82
0.71
Invitrogen
IVGN
75.69
76.91
-1.59
Molecular Devices
MDCC
20.32
20.63
-1.50
PerkinElmer
PKI
19.71
20.39
-3.33
Qiagen
QGEN
13.17
13.1
0.53
Sigma
SIAL
60.34
62.51
-3.47
Stratagene
STGN
8.52
6.96
22.41
Thermo
TMO
30.13
30.76
-2.05
Waters
WAT
42.44
45.2
-6.11
Index Average
33.61
34.37
-2.20
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.